ACC Online Courses

ACC Online Courses offer the cardiovascular community a collection of resources and newly developed, evidence-based educational activities across topics such as lipid management, valvular heart disease, CVD and influenza vaccine, SGLT2i's, and cardiomyopathies.

Stay up to date on the latest science and guidelines, and learn at your own pace through various learning formats including infographics, expert videos, podcasts, and interactive learning modules.

Arrhythmia Detection Toolbox

Increase awareness and knowledge on the various types of devices, their strengths and limitations, and appropriate selection of patients who may benefit from cardiac monitoring.

Find Out More

HCM: Guideline-Driven Care

Hypertrophic cardiomyopathy (HCM) is one of the most common genetic cardiovascular diseases. Access resources and education to address knowledge gaps in the identification and appropriately managing HCM to reduce the burden of disease progression.
Learn More

Understanding Cardiac Amyloidosis

Build greater awareness of the prevalence and diagnosis of cardiac amyloidosis and advancements in imaging technology and treatment, and improve differential diagnosis and expedite referral and treatment.

Learn More

Managing AFib and BTK Inhibitors

Understand the importance of assessing risk, monitoring, and managing AFib and other CV risk factors for cancer patients focused on the treatment for chronic lymphocytic leukemia/lymphoma.
Learn More

Understanding and Managing MR

Improve knowledge in the assessment of Mitral Regurgitation to determine etiology, mechanism and severity to guide timely and optimal intervention strategies and advance patient care.
Learn More

Flu and Cardiovascular Disease

Gain actionable knowledge regarding the connection between influenza and CV outcomes and the role the CV care team plays in directing patients to receive vaccinations.
Learn More

Clinical Spotlight Series

Learn best practices and emerging science across practice-changing topics in care including women's health, SGLT2i's, new nonstatins, hypertrophic cardiomyopathy and cardiac amyloidosis.
Learn More

Lipid Lowering Strategies

Learn to address risk assessment in ASCVD, LDL-C lowering therapies, the science behind PCKS9 inhibitors and how to develop a guideline-driven treatment plan that optimizes therapy for ASCVD patients.
Learn More

HCM Awareness

Improve the diagnosis and appropriate treatment of patients with hypertrophic cardiomyopathy to reduce the burden of disease progression.

Learn More

CV Risk in Diabetes

Learn the emerging science behind the incorporation of SGLT2i's and GLP-1RA's into cardiology practice and best practices for improving coordination of care among a multidisciplinary team.
Learn More